Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Renal Failure
  Free Subscription

Articles published in
Am J Nephrol
    November 2024
  1. KIM I, Min SH, Lee HW, An JN, et al
    Impact of Peritoneal Neutrophil Extracellular Traps on Peritoneal Characteristics and Technical Failure in Patients Undergoing Peritoneal Dialysis.
    Am J Nephrol. 2024 Nov 7:1-17. doi: 10.1159/000542427.
    >> Share

  2. FERREIRA JP, Oliveira AC, Vasques-Novoa F, Leite AR, et al
    Mineralocorticoid receptor antagonist combined with a SGLT2 inhibitor versus SGLT2 inhibitor alone in chronic kidney disease: a meta-analysis of randomized trials.
    Am J Nephrol. 2024 Nov 7:1-13. doi: 10.1159/000541686.
    >> Share

  3. ZOCCALI C, Mallamaci F
    The Interplay of Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Call for Integrated Management.
    Am J Nephrol. 2024 Nov 5:1-4. doi: 10.1159/000541889.
    >> Share

    October 2024
  4. SHIAO CC, Chiu CW, Chang YM, Liu MC, et al
    Comprehensive Evaluation of the Cardiovascular Protective Effects of SGLT2 Inhibitors in Patients with Advanced Chronic Kidney Disease: A Real-World Evidence.
    Am J Nephrol. 2024 Oct 21:1-28. doi: 10.1159/000542132.
    >> Share

  5. CHUANG GT, Hsiung CN, Che TP, Chang YC, et al
    Discovering Novel Loci of Chronic Kidney Disease via Principal Component Analysis based Multiple-trait Genome?wide Association Study.
    Am J Nephrol. 2024 Oct 21:1-25. doi: 10.1159/000541982.
    >> Share

  6. PARK CH, Lim H, Kim YN, Kim JY, et al
    Non-alcoholic Fatty Liver Disease (NAFLD) and its association with kidney and cardiovascular outcomes in moderate to advanced chronic kidney disease.
    Am J Nephrol. 2024 Oct 4:1-23. doi: 10.1159/000541803.
    >> Share

    September 2024
  7. LUO W, Lei L, Lai J, Liu Y, et al
    A risk prediction model for new-onset chronic kidney disease in the elderly.
    Am J Nephrol. 2024 Sep 23:1-26. doi: 10.1159/000541510.
    >> Share

  8. HAMANO T, Koiwa F, Isaka Y, Yokoyama K, et al
    Long-term Efficacy and Safety of Upacicalcet in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Open-label 52-week Study.
    Am J Nephrol. 2024 Sep 19:1-23. doi: 10.1159/000541493.
    >> Share

  9. MURAKAMI M, Fujii N, Kanda E, Kikuchi K, et al
    Association between timing of vascular access creation and mortality in patients initiating hemodialysis: A nationwide cohort study in Japan.
    Am J Nephrol. 2024 Sep 7. doi: 10.1159/000541356.
    >> Share

    August 2024
  10. VANEK L, Gulmez D, Kurnikowski A, Krenn S, et al
    Patient and caregiver perspectives on gender disparity in chronic kidney disease: Questionnaire survey, based on an interview study.
    Am J Nephrol. 2024 Aug 27. doi: 10.1159/000540850.
    >> Share

  11. BISHOP CW, Ashfaq A, Strugnell SA, Choe J, et al
    Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients.
    Am J Nephrol. 2024 Aug 27. doi: 10.1159/000541138.
    >> Share

  12. POLLOCK C, Carrero JJ, Kanda E, Ofori-Asenso R, et al
    The Lived Experience of Patients With Chronic Kidney Disease: Insights From DISCOVER CKD.
    Am J Nephrol. 2024 Aug 22. doi: 10.1159/000541064.
    >> Share

  13. WEIR MR, Rossignol P, Pitt B, Lund LH, et al
    Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients With Heart Failure With or Without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial.
    Am J Nephrol. 2024 Aug 19. doi: 10.1159/000540453.
    >> Share

  14. KIM IS, Lee HS, Jang J, An JN, et al
    Impact of Fat Mass on Osteoporosis, Sarcopenia, and Osteosarcopenia in Peritoneal Dialysis Patients.
    Am J Nephrol. 2024 Aug 17. doi: 10.1159/000540948.
    >> Share

    July 2024
  15. BLOCK GA, Mizani MR, Broumand V, Newby FD, et al
    A Randomized Trial of the IMPACT of Ferric Citrate on Erythropoietin and Intravenous Iron Use in Patients Receiving Dialysis.
    Am J Nephrol. 2024 Jul 5. doi: 10.1159/000540227.
    >> Share

    June 2024
  16. ZIEGLER J, Morley K, Pilcher D, Bellomo R, et al
    Epidemiology of renal replacement therapy for critically ill patients across seven health jurisdictions.
    Am J Nephrol. 2024 Jun 18. doi: 10.1159/000539811.
    >> Share

    May 2024
  17. SHAH AD, Vashisth S, Raker CA, Hu SL, et al
    Trends, Outcomes, and Economic Implications of Peritoneal Dialysis-Associated Peritonitis: A National Cohort Study.
    Am J Nephrol. 2024 May 30. doi: 10.1159/000539452.
    >> Share

  18. MOLONEY BM, Chertow GM, Mc Causland FR
    Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial.
    Am J Nephrol. 2024 May 23. doi: 10.1159/000539451.
    >> Share

  19. GARDEZI AI, Yuan Z, Aziz F, Parajuli S, et al
    Effect of End-Stage Renal Disease Prospective Payment System on Utilization of Peritoneal Dialysis in Patients with Kidney Allograft Failure.
    Am J Nephrol. 2024 May 16. doi: 10.1159/000539062.
    >> Share

  20. VAN REETH O, Caliment A, de la Fuente Garcia I, Niel O, et al
    Safety profile and effectiveness of dapagliflozin in pediatric patients with chronic kidney disease.
    Am J Nephrol. 2024 May 11. doi: 10.1159/000539300.
    >> Share

  21. GENDY N, Brown L, Staunton MK, Garg K, et al
    The Role of Angiopoietins in Cardiovascular Outcomes of Kidney Transplant Recipients- An Ancillary Study From the FAVORIT.
    Am J Nephrol. 2024 May 10. doi: 10.1159/000538878.
    >> Share

    April 2024
  22. ALSULAMI MM, Al-Otaibi NE, Alshahrani WA, Altheaby A, et al
    The predictors and risk factors of two-year rejection in renal transplant patients: A multicenter case-control study.
    Am J Nephrol. 2024 Apr 26. doi: 10.1159/000538963.
    >> Share

    March 2024
  23. LE D, Crews DC, Grams ME, Coresh J, et al
    Association of Sevelamer Initiation with Gastrointestinal Bleeding Hospitalization in Individuals Requiring Hemodialysis.
    Am J Nephrol. 2024 Mar 29. doi: 10.1159/000538253.
    >> Share

  24. BOBOT M, Hak JF, Casolla B, Dehondt JD, et al
    Acute and chronic kidney dysfunction and prognosis following thrombectomy for ischemic stroke.
    Am J Nephrol. 2024 Mar 18. doi: 10.1159/000536493.
    >> Share

  25. TSAI YL, Chung MH, Lin NC, Chen CY, et al
    The risk factors and clinical outcomes in hepatitis B seropositive and seronegative renal transplant patients.
    Am J Nephrol. 2024 Mar 18. doi: 10.1159/000538231.
    >> Share

    February 2024
  26. STAVAS J, Silva AL, Wooldridge TD, Aqeel A, et al
    Rilparencel (Renal Autologous Cell Therapy-REACT(R)) for Chronic Kidney Disease and Type 1 and 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Re-Dosing Triggers.
    Am J Nephrol. 2024 Feb 29. doi: 10.1159/000537942.
    >> Share

  27. MAKAWI AT, Tawfik YMK, Dixon DL, McMahon GM, et al
    Expanding the Impact of SGLT2 Inhibitors in Chronic Kidney Disease.
    Am J Nephrol. 2024 Feb 28:1-4. doi: 10.1159/000536540.
    >> Share

  28. CROUCH E, Yell N, Herbert L, Browne T, et al
    Availability and quality of dialysis care in rural versus urban U.S. counties.
    Am J Nephrol. 2024 Feb 11. doi: 10.1159/000537763.
    >> Share

    January 2024
  29. FISHBANE S, Clegg DJ, Lerma EV, Rastogi A, et al
    Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post-hoc Analysis of KALM-1 and KALM-2.
    Am J Nephrol. 2024 Jan 22. doi: 10.1159/000534227.
    >> Share

  30. PEREZ-GOMEZ A, Fernandez L, Schanstra JP, Klein J, et al
    Klotho and Mortality in Chronic Kidney Disease: Actor, Risk Factor, or Predictor?
    Am J Nephrol. 2024 Jan 10:1-3. doi: 10.1159/000535752.
    >> Share

  31. ZAHR RS, Saraf SL
    Sickle Cell Disease and CKD: An Update.
    Am J Nephrol. 2024;55:56-71.
    >> Share

  32. HORI M, Takahashi H, Kondo C, Hayashi F, et al
    Association between Serum 25-Hydroxyvitamin D Levels and Sarcopenia in Patients Undergoing Chronic Haemodialysis.
    Am J Nephrol. 2024;55:399-405.
    >> Share

  33. WANG Z, Zhou X, Shi S, Liu L, et al
    Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study.
    Am J Nephrol. 2024;55:529-538.
    >> Share

    December 2023
  34. HAN S, Zhang X, Wang X, Wang Y, et al
    Association Between Serum Klotho and All-Cause Mortality in Chronic Kidney Disease: Evidence From a Prospective Cohort Study.
    Am J Nephrol. 2023 Dec 16. doi: 10.1159/000535808.
    >> Share

  35. MEDAURA JA, Zhou M, Ficociello LH, Anger MS, et al
    Serum phosphorus management with sucroferric oxyhydroxide as a first-line phosphate binder within the first year of hemodialysis.
    Am J Nephrol. 2023 Dec 13. doi: 10.1159/000535754.
    >> Share

  36. NOPPAKUN K, Nochaiwong S, Tantraworasin A, Khorana J, et al
    Mortality rates and a clinical predictive model for the elderly on maintenance hemodialysis: A large observational cohort study of 17,354 Asian patients.
    Am J Nephrol. 2023 Dec 8. doi: 10.1159/000535669.
    >> Share

    November 2023
  37. ELENJICKAL EJ, Travlos CK, Marques P, Mavrakanas TA, et al
    Anticoagulation in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2023 Nov 30. doi: 10.1159/000535546.
    >> Share

  38. GAO LQ, Xue CC, Cui J, Xu J, et al
    Diabetic Retinopathy and Chronic Kidney Disease: Associations and Comorbidities in a Large Diabetic Population: The Tongren Health Care Study.
    Am J Nephrol. 2023 Nov 10. doi: 10.1159/000535059.
    >> Share

  39. ONG SW, Kitchlu A, Cherney DZI, Leung K, et al
    Virtual Pharmacy: An Integrated Collaborative Redesign Targeting Medication-related Problems in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2023 Nov 8. doi: 10.1159/000535094.
    >> Share

  40. NAKASHIMA A, Miyawaki Y, Komaba H, Kurita N, et al
    Proton pump inhibitors and hyporesponsiveness to erythropoiesis stimulating agents in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study.
    Am J Nephrol. 2023 Nov 7. doi: 10.1159/000534701.
    >> Share

    October 2023
  41. WANG Y, Chen X, Zhu H, Guo Z, et al
    Efficacy and safety of ferric citrate on hyperphosphatemia among Chinese patients with chronic kidney disease undergoing hemodialysis: a phase III multicenter randomized open-label active-drug controlled study.
    Am J Nephrol. 2023 Oct 9. doi: 10.1159/000534484.
    >> Share

  42. MASE K, Yamagata K, Yamamoto H, Tsuruya K, et al
    Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in patients with non-dialysis-dependent chronic kidney disease (RADIANCE-CKD Study).
    Am J Nephrol. 2023 Oct 4. doi: 10.1159/000534438.
    >> Share

  43. YUAN CY, Gao YC, Lin Y, Liu L, et al
    Effects of Mineralocorticoid Receptor Antagonists for Chronic Kidney Disease: A Systemic Review and Meta-Analysis.
    Am J Nephrol. 2023 Oct 4. doi: 10.1159/000534366.
    >> Share

  44. FAITATZIDOU D, Karagiannidis AG, Theodorakopoulou MP, Xanthopoulos A, et al
    Autonomic nervous system dysfunction in peritoneal dialysis patients: an underrecognized cardiovascular risk factor?
    Am J Nephrol. 2023 Oct 3. doi: 10.1159/000534318.
    >> Share

  45. TSAI HL, Lin TC, Lin NC, Yang HH, et al
    Risk factors for fractures in renal transplantation: a population-based cohort study.
    Am J Nephrol. 2023 Oct 2. doi: 10.1159/000533125.
    >> Share

    September 2023
  46. CHINNADURAI R, Rengarajan S, Budden JJ, Quinn CM, et al
    Maintaining renin-angiotensin-aldosterone system inhibitor treatment with patiromer in hyperkalaemic chronic kidney disease patients: comparison of a propensity-matched real-world population with AMETHYST-DN.
    Am J Nephrol. 2023 Sep 19. doi: 10.1159/000533753.
    >> Share

  47. YOU AS, Norris KC, Kataoka-Yahiro M, Davis J, et al
    Racial Disparities in End-Stage Kidney Disease Outcomes Among Asians and Native Hawaiians and Other Pacific Islanders Across Geographic Residence.
    Am J Nephrol. 2023 Sep 19. doi: 10.1159/000534052.
    >> Share

  48. KOYA D, Anker SD, Ruilope LM, Rossing P, et al
    Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis.
    Am J Nephrol. 2023 Sep 14:1-9. doi: 10.1159/000532102.
    >> Share

  49. MENDONCA LCF, Vieira MB, Sergio Neves J, Castro Chaves P, et al
    A 4-variable model to predict cardio-kidney events and mortality in chronic kidney disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Am J Nephrol. 2023 Sep 6. doi: 10.1159/000533223.
    >> Share

    August 2023
  50. LAI SW
    Comment on Kang et al.'s "Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis".
    Am J Nephrol. 2023 Aug 17:1-2. doi: 10.1159/000533172.
    >> Share

  51. CHEN H, Tang H, Huang J, Luo N, et al
    Life's Essential 8 and Mortality in US Adults with Chronic Kidney Disease.
    Am J Nephrol. 2023 Aug 17. doi: 10.1159/000533257.
    >> Share

  52. HU H, Wu C, Kwok JYY, Ho MH, et al
    Effects of different exercises on physical function, dialysis adequacy, and health-related quality of life in maintenance hemodialysis patients: A systematic review and network meta-analysis.
    Am J Nephrol. 2023 Aug 3. doi: 10.1159/000532109.
    >> Share

    July 2023
  53. PATEL S, Trujillo Rivera EA, Raman VK, Faselis C, et al
    Impact of the COVID-19 pandemic on the provision of dialysis service and mortality in Veterans receiving maintenance hemodialysis in the VA: an interrupted time-series analysis.
    Am J Nephrol. 2023 Jul 31. doi: 10.1159/000532105.
    >> Share

    June 2023
  54. TAGAYA T, Hayashi H, Ogata S, Takahashi K, et al
    Tolvaptan's association with low risk of acute kidney injury in patients with advanced chronic kidney disease and acute decompensated heart failure.
    Am J Nephrol. 2023 Jun 29. doi: 10.1159/000531692.
    >> Share

  55. GREENLUND IM, Covassin N, Somers VK
    Hitting the Snooze Button on Chronic Kidney Disease.
    Am J Nephrol. 2023 Jun 21. doi: 10.1159/000531625.
    >> Share

  56. IATRIDI F, Theodorakopoulou MP, Karpetas A, Sgouropoulou V, et al
    Association of intradialytic hypertension with future cardiovascular events and mortality in hemodialysis patients: effects of ambulatory blood pressure.
    Am J Nephrol. 2023 Jun 9. doi: 10.1159/000531477.
    >> Share

    May 2023
  57. LI SY, Chen CY, Tsai MT, Lin NC, et al
    Hybrid Method for Peritoneal Dialysis Catheter Insertion: A New Technique for Improved Outcomes and Reduced Costs.
    Am J Nephrol. 2023 May 30. doi: 10.1159/000531162.
    >> Share

  58. JIANG B, Tang D, Dai N, Huang C, et al
    Association of self-reported nighttime sleep duration with chronic kidney disease: China Health and Retirement Longitudinal Study.
    Am J Nephrol. 2023 May 30. doi: 10.1159/000531261.
    >> Share

  59. LI X, Qureshi AR, Suliman ME, Heimburger O, et al
    Interleukin-6 to albumin ratio as a superior predictor of mortality in end stage kidney disease patients.
    Am J Nephrol. 2023 May 24. doi: 10.1159/000531191.
    >> Share

  60. PARK JH, Park HC, Kim DH, Lee YK, et al
    Mortality and risk factors in very elderly patients who start hemodialysis: Korean Renal Data System (KORDS), 2016-2020.
    Am J Nephrol. 2023 May 18:1. doi: 10.1159/000530933.
    >> Share

  61. KANG SH, Kim BY, Son EJ, Kim GO, et al
    Comparison between the effects of allopurinol and febuxostat on the survival of patents on maintenance hemodialysis.
    Am J Nephrol. 2023 May 18:1. doi: 10.1159/000530972.
    >> Share

  62. GREGG LP, Richardson P, Herrera MA, Akeroyd J, et al
    Documented adverse drug reactions and discontinuation of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Am J Nephrol. 2023 May 18:1. doi: 10.1159/000530988.
    >> Share

  63. TANG C, Wen XY, Lv J, Shi S, et al
    Discontinuation of Renin-Angiotensin System Inhibitors and Clinical Outcomes in Chronic Kidney Disease: A Systemic Review and Meta-Analysis.
    Am J Nephrol. 2023 May 18. doi: 10.1159/000531000.
    >> Share

  64. PACKER M
    Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients With Chronic Kidney Disease and Renal Anemia.
    Am J Nephrol. 2023 May 16. doi: 10.1159/000531084.
    >> Share

    April 2023
  65. ORTIZ-SORIANO V, Cama-Olivares A, Liu LJ, Armentrout B, et al
    The optimization of outpatient hemodialysis management for AKI-D patients: A quality improvement study.
    Am J Nephrol. 2023 Apr 8. doi: 10.1159/000530444.
    >> Share

  66. PLANTINGA LC, Bender AA, Urbanski M, Hoge C, et al
    Work Experiences of the Interdisciplinary Dialysis Workforce in the United States: A Cross-Sectional Survey.
    Am J Nephrol. 2023 Apr 7. doi: 10.1159/000530553.
    >> Share

    March 2023
  67. ZHAO Q, He Y, Wu N, Wang L, et al
    Non-pharmacological Interventions to Improve Physical Function in Patients with End-stage Renal Disease: A Network Meta-analysis.
    Am J Nephrol. 2023 Mar 30. doi: 10.1159/000530219.
    >> Share

  68. SINGH AP, Kalil R, Weir MR
    Role of Sodium-Glucose Cotransporter 2 inhibitors for management of diabetes mellitus in renal transplant recipients; and management strategies for post-transplant hypertension.
    Am J Nephrol. 2023 Mar 24. doi: 10.1159/000530296.
    >> Share

  69. MURAKAMI M, Fujii N, Kanda E, Kikuchi K, et al
    Association of four types of vascular access including arterial superficialization with mortality in maintenance hemodialysis patients: a nationwide cohort study in Japan.
    Am J Nephrol. 2023 Mar 14. doi: 10.1159/000529991.
    >> Share

  70. RIZK JG, Hsiung JT, Arif Y, Hashemi L, et al
    Triglycerides and Renal Outcomes according to Albuminuria and in Consideration of other Metabolic Syndrome Components in Diabetic US Veterans.
    Am J Nephrol. 2023 Mar 8. doi: 10.1159/000529414.
    >> Share

    February 2023
  71. YANG CW, Lin MC, Shu KH, Tung KT, et al
    Extremely Low Dose of Erythropoiesis-Stimulating Agent May be Associated with Increased Mortality in Hemodialysis Patients.
    Am J Nephrol. 2023 Feb 28. doi: 10.1159/000529806.
    >> Share

  72. TUTTLE KR, Wilson JM, Lin Y, Qian HR, et al
    Indicators of Kidney Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease Treated With Dulaglutide.
    Am J Nephrol. 2023 Feb 8. doi: 10.1159/000529374.
    >> Share

  73. MACDOUGALL IC, Meadowcroft AM, Blackorby A, Cizman B, et al
    Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D).
    Am J Nephrol. 2023 Feb 3. doi: 10.1159/000528696.
    >> Share

    January 2023
  74. MENDE CW, Samarakoon R, Higgins PJ
    [Mineralocorticoid receptor (MR)-associated mechanisms in diabetic kidney disease and clinical significance of MR antagonists].
    Am J Nephrol. 2023 Jan 20. doi: 10.1159/000528783.
    >> Share

  75. CHEN TK, Coca SG, Thiessen-Philbrook HR, Heerspink HJL, et al
    [Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes].
    Am J Nephrol. 2023 Jan 11. doi: 10.1159/000528918.
    >> Share

  76. THEOFILIS P, Vordoni A, Kalaitzidis RG
    Epidemiology, Pathophysiology, and Clinical Perspectives of Intradialytic Hypertension.
    Am J Nephrol. 2023;54.
    >> Share

  77. PUAPATANAKUL P, Banjongjit A, Kanjanabuch T, Surintrspanont J, et al
    Clinicopathological Characteristics and Impacts on Clinical Outcomes of Thrombotic Microangiopathy Lesions in Patients with Immunoglobulin A Nephropathy in Thailand.
    Am J Nephrol. 2023;54.
    >> Share

  78. ZHANG S, Chen X, Hou Z, Xia P, et al
    Renal Outcomes in Older Adults with Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: A New Prediction Model.
    Am J Nephrol. 2023;54.
    >> Share

    December 2022
  79. NAKAGAWA Y, Komaba H, Wada T, Takahashi H, et al
    Serum sclerostin levels and mortality in hemodialysis patients: An 8-year prospective study.
    Am J Nephrol. 2022 Dec 27. doi: 10.1159/000528795.
    >> Share

  80. CHIU V, Gross AL, Chu NM, Segev D, et al
    Domains for a Comprehensive Geriatric Assessment of Older Adults with Chronic Kidney Disease: Results from the CRIC Study.
    Am J Nephrol. 2022 Dec 9. doi: 10.1159/000528602.
    >> Share

  81. FAITATZIDOU D, Dipla K, Theodorakopoulou MP, Koutlas A, et al
    Hemodialysis effects on autonomic function: results of linear and non-linear analysis of heart-rate-variability at rest and in response to physical and mental stress tests.
    Am J Nephrol. 2022 Dec 8. doi: 10.1159/000528322.
    >> Share

  82. LI X, Lindholm B
    Cardiovascular Risk Prediction in Chronic Kidney Disease.
    Am J Nephrol. 2022 Dec 8. doi: 10.1159/000528560.
    >> Share

  83. MATHUR VS, Wesson DE, Li E, Tangri N, et al
    Factors Affecting the Decision to Initiate Dialysis: A National Survey of United States Nephrologists.
    Am J Nephrol. 2022 Dec 7. doi: 10.1159/000528167.
    >> Share

  84. WESSON DE, Mathur V, Tangri N
    Metabolic Basis and Pathogenesis of Skeletal Muscle Dysfunction as Cause of Frailty in Chronic Kidney Disease.
    Am J Nephrol. 2022 Dec 6:1-13. doi: 10.1159/000526679.
    >> Share

  85. TIONG MK, Holt SG, Ford ML, Smith ER, et al
    Serum Calciprotein Monomers and Chronic Kidney Disease Progression.
    Am J Nephrol. 2022 Dec 6:1-10. doi: 10.1159/000526609.
    >> Share

    November 2022
  86. AGARWAL R, Anand S, Eckardt KU, Luo W, et al
    Overall Adverse Event Profile of Vadadustat for the Treatment of Anemia Associated With Chronic Kidney Disease in Phase 3 Trials.
    Am J Nephrol. 2022 Nov 30. doi: 10.1159/000528443.
    >> Share

  87. TANGRI N, Mathur V, Reaven N, Funk SE, et al
    Relationship between Metabolic Acidosis and Chronic Kidney Disease Progression across Racial and Ethnic Groups: An Observational, Retrospective Cohort Study.
    Am J Nephrol. 2022 Nov 8:1-11. doi: 10.1159/000527036.
    >> Share

  88. SERRANO M, Srivastava A, Buck G, Zhu B, et al
    Dietary Protein and Fiber Affect Gut Microbiome and Treg/Th17 Commitment in Chronic Kidney Disease Mice.
    Am J Nephrol. 2022 Nov 7:1-6. doi: 10.1159/000526957.
    >> Share

  89. QU X, Tong X, Hou X, Zhang J, et al
    Trends in Adherence to Recommended Physical Activity and Its Association with Mortality and Disease Progression among US Adults with Chronic Kidney Disease.
    Am J Nephrol. 2022 Nov 7:1-12. doi: 10.1159/000526956.
    >> Share

  90. ALLINOVI M, Bergesio F, Cappelli F, Chiappini MG, et al
    Is Hereditary Transthyretin Amyloidosis the Third Leading Cause of Monogenic Chronic Kidney Disease, Only Behind ADPKD and Alport Disease?
    Am J Nephrol. 2022 Nov 7:1-4. doi: 10.1159/000526955.
    >> Share

    October 2022
  91. BURROWS NR, Koyama AK, Choudhury D, Yu W, et al
    Age-Related Association between Multimorbidity and Mortality in US Veterans with Incident Chronic Kidney Disease.
    Am J Nephrol. 2022 Oct 7:1-11. doi: 10.1159/000526254.
    >> Share

    September 2022
  92. LIU Q, Bai B, Liu F, Chen Y, et al
    Long-Term Trends in Risk Factor Management in Respondents with Chronic Kidney Disease in the USA.
    Am J Nephrol. 2022 Sep 20:1-10. doi: 10.1159/000525733.
    >> Share

    August 2022
  93. XU X, Ma T, Tian X, Li S, et al
    Telemedicine and Clinical Outcomes in Peritoneal Dialysis: A Propensity-Matched Study.
    Am J Nephrol. 2022 Aug 17:1-11. doi: 10.1159/000525917.
    >> Share

    July 2022
  94. EINBINDER Y, Perl J, Nacasch N, Bnaya A, et al
    Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients.
    Am J Nephrol. 2022 Jul 18:1-5. doi: 10.1159/000525309.
    >> Share

    June 2022
  95. THEOFILIS P, Vordoni A, Kalaitzidis RG
    The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?
    Am J Nephrol. 2022 Jun 29:1-10. doi: 10.1159/000525441.
    >> Share

  96. LEGENDRE B, Lobbedez T, Couchoud C, Lassalle M, et al
    Switch from Hemodialysis to Peritoneal Dialysis: Does the Time Spent on Hemodialysis Impact Outcomes in Peritoneal Dialysis?
    Am J Nephrol. 2022 Jun 22:1-10. doi: 10.1159/000524960.
    >> Share

  97. VRIST MH, Ostergaard AMH, Langaa SS, Mose FH, et al
    Bone Turnover, Mineralization, and Volume Estimated by 18F-Sodium Fluoride PET/CT and Biomarkers in Chronic Kidney Disease: Mineral and Bone Disorder Compared with Bone Biopsy.
    Am J Nephrol. 2022 Jun 7:1-13. doi: 10.1159/000524961.
    >> Share

    May 2022
  98. WANG K, Qian D, Hu Y, Cheng Y, et al
    Nut Consumption and Effects on Chronic Kidney Disease and Mortality in the United States.
    Am J Nephrol. 2022 May 24:1-10. doi: 10.1159/000524382.
    >> Share

  99. BISHOP CW, Strugnell SA, Csomor P, Kaiser E, et al
    Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
    Am J Nephrol. 2022 May 12:1-9. doi: 10.1159/000524289.
    >> Share

    April 2022
  100. MURRAY AM, Slinin Y, Tupper DE, Pederson SL, et al
    Kidney-Metabolic Factors Associated with Cognitive Impairment in Chronic Kidney Disease: A Pilot Study.
    Am J Nephrol. 2022 Apr 28:1-11. doi: 10.1159/000524166.
    >> Share

  101. GOODKIN DA, Zhao J, Cases A, Nangaku M, et al
    Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient.
    Am J Nephrol. 2022 Apr 22:1-10. doi: 10.1159/000523947.
    >> Share

  102. AGRAWAL D, Varade D, Shah H, Nazar A, et al
    Desidustat in Anemia due to Non-Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-ND).
    Am J Nephrol. 2022 Apr 22:1-9. doi: 10.1159/000523961.
    >> Share

  103. GANG S, Khetan P, Varade D, Chinta VR, et al
    Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D).
    Am J Nephrol. 2022 Apr 22:1-9. doi: 10.1159/000523949.
    >> Share

  104. KIM DH, Park HC, Cho A, Kim J, et al
    Nurse Caseload and Patient Survival in Hemodialysis Units: A Korean Nationwide Cohort Study.
    Am J Nephrol. 2022 Apr 20:1-9. doi: 10.1159/000524110.
    >> Share

    March 2022
  105. GOLLIE JM, Patel SS, Harris-Love MO, Cohen SD, et al
    Fatigability and the Role of Neuromuscular Impairments in Chronic Kidney Disease.
    Am J Nephrol. 2022 Mar 28:1-11. doi: 10.1159/000523714.
    >> Share

  106. BLEYER AJ, Westemeyer M, Xie J, Bloom MS, et al
    Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel.
    Am J Nephrol. 2022 Mar 24:1-10. doi: 10.1159/000522226.
    >> Share

  107. SCHREIER DJ, Rule AD, Kashani KB, Mara KC, et al
    Nephrotoxin Exposure in the 3 Years following Hospital Discharge Predicts Development or Worsening of Chronic Kidney Disease among Acute Kidney Injury Survivors.
    Am J Nephrol. 2022 Mar 16:1-9. doi: 10.1159/000522139.
    >> Share

  108. OKUBO A, Doi T, Morii K, Nishizawa Y, et al
    Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients.
    Am J Nephrol. 2022 Mar 8:1-7. doi: 10.1159/000522225.
    >> Share

    February 2022
  109. SOOHOO M, Obi Y, Rivara MB, Adams SV, et al
    Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism.
    Am J Nephrol. 2022 Feb 28:1-12. doi: 10.1159/000521508.
    >> Share

  110. FUJII N, Hamano T, Hsu JY, Imai E, et al
    A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.
    Am J Nephrol. 2022 Feb 28:1-14. doi: 10.1159/000521386.
    >> Share

  111. TSAI HC, Ou SM, Wu CC, Huang CC, et al
    Pentraxin 3 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Chronic Hemodialysis Patients.
    Am J Nephrol. 2022 Feb 25:1-9. doi: 10.1159/000522049.
    >> Share

  112. ZHANG J, Fuhrer T, Ye H, Kwan B, et al
    High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
    Am J Nephrol. 2022 Feb 23:1-11. doi: 10.1159/000521940.
    >> Share

  113. SHASHAR M, Nacasch N, Grupper A, Benchetrit S, et al
    Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients.
    Am J Nephrol. 2022 Feb 16:1-8. doi: 10.1159/000521676.
    >> Share

  114. VARETA G, Georgianos PI, Vaios V, Sgouropoulou V, et al
    Epidemiology of Hypertension among Patients on Peritoneal Dialysis Using Standardized Office and Ambulatory Blood Pressure Recordings.
    Am J Nephrol. 2022 Feb 4:1-9. doi: 10.1159/000521861.
    >> Share

    January 2022
  115. BENMIRA AM, Moranne O, Prelipcean C, Pambrun E, et al
    Direct Determination rather than Oscillometric Estimation of Systolic Blood Pressure in Patients with Severe Chronic Kidney Disease.
    Am J Nephrol. 2022 Jan 12:1-9. doi: 10.1159/000520996.
    >> Share

  116. BHANDARI SK, Zhou H, Shaw SF, Shi J, et al
    Causes of Death in End-Stage Kidney Disease: Comparison between the United States Renal Data System and a Large Integrated Health Care System.
    Am J Nephrol. 2022 Jan 11:1-9. doi: 10.1159/000520466.
    >> Share

  117. ZHU B, Liu WH, Lin Y, Li Q, et al
    Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
    Am J Nephrol. 2022;53:455-469.
    >> Share

    December 2021
  118. DIAMANTIDIS CJ, Zepel L, Wang V, Smith VA, et al
    Disparities in Chronic Kidney Disease Progression by Medicare Advantage Enrollees.
    Am J Nephrol. 2021;52:949-957.
    >> Share

  119. YOU HS, Shin SJ, Kim J, Kang HT, et al
    Statin Use and Incidence of Chronic Kidney Disease in Hypercholesterolemia Patients with Normal Renal Function.
    Am J Nephrol. 2021 Dec 3:1-9. doi: 10.1159/000520532.
    >> Share

    November 2021
  120. OTOBE Y, Yamada M, Hiraki K, Onari S, et al
    Physical Exercise Improves Cognitive Function in Older Adults with Stage 3-4 Chronic Kidney Disease: A Randomized Controlled Trial.
    Am J Nephrol. 2021 Nov 30:1-11. doi: 10.1159/000520230.
    >> Share

  121. PAIK JM, Zhuo M, York C, Tsacogianis T, et al
    Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013-2017.
    Am J Nephrol. 2021 Nov 23:1-10. doi: 10.1159/000520028.
    >> Share

  122. THOMSON BKA, Pilkey NG, Monteith B, Holden RM, et al
    A Scoping Review of Alternative Anticoagulation Strategies for Hemodialysis Patients with a Mechanical Heart Valve.
    Am J Nephrol. 2021;52.
    >> Share

  123. WEE HN, Liu JJ, Ching J, Kovalik JP, et al
    The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease.
    Am J Nephrol. 2021 Nov 9:1-17. doi: 10.1159/000519811.
    >> Share

  124. HU S, Wang D, Ma T, Yuan F, et al
    Association between Preoperative Monocyte-to-Lymphocyte Ratio and Late Arteriovenous Fistula Dysfunction in Hemodialysis Patients: A Cohort Study.
    Am J Nephrol. 2021 Nov 8:1-7. doi: 10.1159/000519822.
    >> Share

    October 2021
  125. JELANI QU, Llanos-Chea F, Bogra P, Trejo-Paredes C, et al
    Guideline-Directed Medical Therapy in Patients with Chronic Kidney Disease Undergoing Peripheral Vascular Intervention.
    Am J Nephrol. 2021 Oct 27:1-9. doi: 10.1159/000519484.
    >> Share

  126. GOLDBERG A, Garcia-Arroyo F, Sasai F, Rodriguez-Iturbe B, et al
    Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease.
    Am J Nephrol. 2021 Oct 21:1-8. doi: 10.1159/000519491.
    >> Share

  127. SELLIER AB, Seiler-Mussler S, Emrich IE, Bohm M, et al
    FGFR4 and Klotho Polymorphisms Are Not Associated with Cardiovascular Outcomes in Chronic Kidney Disease.
    Am J Nephrol. 2021 Oct 21:1-9. doi: 10.1159/000519274.
    >> Share

    September 2021
  128. EREZ D, Fanadka F, Benchetrit S, Cohen-Hagai K, et al
    The Combined Prognostic Significance of Alkaline Phosphatase and Intracranial Arterial Calcifications in Hemodialysis Patients.
    Am J Nephrol. 2021 Sep 17:1-7. doi: 10.1159/000518399.
    >> Share

  129. THEOFILIS P, Vordoni A, Koukoulaki M, Vlachopanos G, et al
    Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives.
    Am J Nephrol. 2021 Sep 17:1-9. doi: 10.1159/000518456.
    >> Share

  130. CIARDULLO S, Ballabeni C, Trevisan R, Perseghin G, et al
    Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease.
    Am J Nephrol. 2021;52:666-672.
    >> Share

    January 2021
  131. RAJKUMAR T, Wong J, Harvey M, Weidersehn L, et al
    Comparison of Sampling Methods for International Normalized Ratio Monitoring in Haemodialysis Patients (INRHaemo Study).
    Am J Nephrol. 2021;52:17-25.
    >> Share

  132. SY J, Hsiung JT, Edgett D, Kalantar-Zadeh K, et al
    Cardiovascular and Bleeding Outcomes with Anticoagulants across Kidney Disease Stages: Analysis of a National US Cohort.
    Am J Nephrol. 2021;52:199-208.
    >> Share

  133. SHESHADRI A, Kittiskulnam P, Delgado C, Sudore RL, et al
    Association of Cognitive Function Screening Results with Adherence and Performance in a Pedometer-Based Intervention.
    Am J Nephrol. 2021;52:420-428.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016